OWC Pharmaceutical Research (OWC Pharmaceutical Research) Accounts Payable & Accrued Expense : $0.29 Mil (As of Sep. 2019)

View and export this data going back to 2008. Start your Free Trial

What is OWC Pharmaceutical Research Accounts Payable & Accrued Expense?

OWC Pharmaceutical Research's quarterly accounts payable & accrued expense declined from Mar. 2019 ($0.16 Mil) to Jun. 2019 ($0.10 Mil) but then increased from Jun. 2019 ($0.10 Mil) to Sep. 2019 ($0.29 Mil).

OWC Pharmaceutical Research's annual accounts payable & accrued expense increased from Dec. 2016 ($0.01 Mil) to Dec. 2017 ($0.04 Mil) and increased from Dec. 2017 ($0.04 Mil) to Dec. 2018 ($0.10 Mil).

OWC Pharmaceutical Research Accounts Payable & Accrued Expense Historical Data

The historical data trend for OWC Pharmaceutical Research's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OWC Pharmaceutical Research Accounts Payable & Accrued Expense Chart

OWC Pharmaceutical Research Annual Data

Trend

Dec08

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

0.06

0.03

0.01

0.04

0.10

OWC Pharmaceutical Research Quarterly Data
	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															0.23	0.10	0.16	0.10	0.29

OWC Pharmaceutical Research Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

OWC Pharmaceutical Research (OWC Pharmaceutical Research) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » OWC Pharmaceutical Research Corp (OTCPK:OWCP) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

2 Ben Gurion Street, Ramat Gan, ISR, 5257334

Website

http://www.owcpharma.com

OWC Pharmaceutical Research Corp is a medical cannabis research and development company. The firm through its subsidiary researches and develops cannabis-based products and treatments specifically designed for multiple myeloma, psoriasis, fibromyalgia, post-traumatic stress disorder (PTSD), migraine, sexual function and skin disorders. It also provides consulting services to governmental and private entities to assist them with developing and implementing tailor-made medical cannabis program.

Executives

Asher Zwebner

director, officer: CHIEF FINANCIAL OFFICER

CDOOR CORPORATION, 20 A REHOV SHAREI TORAH BAYIT VEGAN, JERUSALEM L3 96387